These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1386 related articles for article (PubMed ID: 27333332)
1. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center. Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332 [TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan. Ono N; Niiro H; Ueda A; Sawabe T; Nishizaka H; Furugo I; Yoshizawa S; Yoshizawa S; Tsukamoto H; Kiyohara C; Tada Y; Horiuchi T Rheumatol Int; 2015 Mar; 35(3):555-9. PubMed ID: 25129031 [TBL] [Abstract][Full Text] [Related]
4. Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study. Ikeda S; Arita M; Misaki K; Kashiwagi Y; Ito Y; Yamada H; Hotta M; Nishiyama A; Ito A; Noyama M; Koyama T; Notohara K; Ishida T BMC Pulm Med; 2015 Jul; 15():78. PubMed ID: 26223225 [TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. Chang DY; Li ZY; Chen M; Zhao MH Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327 [TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis. Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364 [TBL] [Abstract][Full Text] [Related]
7. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA; Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification. Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643 [TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Csernok E; Ahlquist D; Ullrich S; Gross WL Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006 [TBL] [Abstract][Full Text] [Related]
10. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U; Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483 [TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis. Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158 [TBL] [Abstract][Full Text] [Related]
14. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study. Berti A; Cornec D; Crowson CS; Specks U; Matteson EL Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446 [TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings. Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477 [TBL] [Abstract][Full Text] [Related]
17. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Cabral DA; Canter DL; Muscal E; Nanda K; Wahezi DM; Spalding SJ; Twilt M; Benseler SM; Campillo S; Charuvanij S; Dancey P; Eberhard BA; Elder ME; Hersh A; Higgins GC; Huber AM; Khubchandani R; Kim S; Klein-Gitelman M; Kostik MM; Lawson EF; Lee T; Lubieniecka JM; McCurdy D; Moorthy LN; Morishita KA; Nielsen SM; O'Neil KM; Reiff A; Ristic G; Robinson AB; Sarmiento A; Shenoi S; Toth MB; Van Mater HA; Wagner-Weiner L; Weiss JE; White AJ; Yeung RS; Arthritis Rheumatol; 2016 Oct; 68(10):2514-26. PubMed ID: 27111558 [TBL] [Abstract][Full Text] [Related]
18. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California. Singh D; Sukumaran S Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890 [TBL] [Abstract][Full Text] [Related]
19. Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation. Néel A; Espitia-Thibault A; Arrigoni PP; Volteau C; Rimbert M; Masseau A; Agard C; Fakhouri F; Liberge R; Hamidou M Semin Arthritis Rheum; 2018 Aug; 48(1):70-76. PubMed ID: 29336783 [TBL] [Abstract][Full Text] [Related]
20. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]